|Title||Pharmaceutical pollution in India An emerging concern|
|Publication Type||Research Reports|
|Year of Publication||2020|
|Keywords||india, Contamination, Delhi, NGO, SAICM, exposure, Environment, Yamuna, Policy, Toxicity, Sikkim, Toxics Link, Ecosystem, CPCB, WHO, Samples, human health, Hyderabad, Baddi, COVID-19, Sirsa river, biodegradable, drinking water, Anti-microbial resistance, effluents, legislation, Pharmaceutical pollution, Nalagarh, synthetic chemicals, waste stream, Pharmaceutical industry, generic drugs, production hub, cocktail effect, regulatory mechanism, Safe Drinking Water Act, pharma sector, MoEF&CC, Andhra Pradesh Pollution Control Board, Ganga, Ahmedabad, Teesta river, treatment facilities,|
Over the last few decades, India has emerged as an important pharmaceutical production hub of the world.As per the Directory of Pharmaceutical Manufacturing Units in India - National Pharmaceutical Pricing Authority (NPPA),2007, the country has 10563 pharmaceutical manufacturers withnthe maximum of them concentrated in 5 states namely, Maharashtra (29.7%),Gujarat (14.4%), West Bengal (7.2%), Andhra Pradesh (6.9%) and Tamil Nadu (5.4%).However, recently Baddi of Himachal Pradesh and Sikkim have emerged as the new pharmaceutical production hubs of the country.With India emerging as a major producer of generic drug manufacturer and with the ever-increasing use of drugs in the country, there is a need to develop appropriate regulatory mechanisms,with adequate monitoring system in place, so that the impact of the pharmaceutical pollution can be reduced.